Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Pharol says Oi bankruptcy has no material financial impact on group

Pharol says Oi bankruptcy has no material financial impact on group

ReutersReuters2026/08/26 19:13
  • Pharol flagged no material financial impact from Oi’s bankruptcy, following a Rio de Janeiro court ruling upholding the conversion to bankruptcy.
  • The company maintained its assessment of known tax contingencies, citing no material change based on currently available information.
  • Pharol plans to monitor the proceedings for developments that could alter its current impact assessment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharol SA published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A historic breakthrough in pancreatic cancer treatment! FDA approves RevMed's targeted new drug, with sales expected to exceed $9 billion by 2032.

The oral new drug daraxonrasib from RevMed has been officially approved by the FDA for market launch, with an annual list price exceeding $475,000. It is the first targeted drug aimed at the key molecular pathogenic mechanism of pancreatic cancer. Clinical trials show that the median survival time for patients almost doubled, increasing from 6.7 months to 13.2 months. According to data from the American Cancer Society, over 52,000 people are expected to die from pancreatic cancer this year. Wall Street predicts that sales could surpass $9 billions by 2032.

华尔街见闻2026/08/26 20:06